Clinical Trials · NCT06083675
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Withdrawn
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 0
- Start date
- Jan 2024
- Locations
- 100 sites, 13 countries
- Primary endpoint
- Change in glycated haemoglobin (HbA1c)